citalopram and olanzapine

citalopram has been researched along with olanzapine in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.22)	18.2507
2000's	25 (55.56)	29.6817
2010's	15 (33.33)	24.3611
2020's	4 (8.89)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Keserü, GM	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Jia, L; Sun, H	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Sen, S; Sinha, N	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Adli, M; Bauer, M; Rossius, W	1
Goodnick, PJ	1
Kaschka, WP; König, F; Neuhöffer-Weiss, M; Petersdorff, T; von Hippel, C; Wolfersdorf, M	1
Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR	1
Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Lebowitz, B; Lieberman, JA; Lyketsos, CG; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Schneider, LS; Small, GW; Tariot, PN	1
Haslett, CD; Kumar, S	1
Downes, F; Isbister, GK; Whyte, IM	1
Duggal, HS; Gates, C; Pathak, PC	1
Hossain, A; Mahgoub, NA	1
Gorman, JM; Ose, BL; Pandurangi, AK	1
Horak, EL; Jenkins, AJ	1
Kozian, R	1
Koht, J; Refsum, H; Solberg, DK	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G	1
Arnt, J; Bang-Andersen, B; Brennum, LT; Christoffersen, CT; Di Matteo, V; Didriksen, M; Esposito, E; Hertel, P; Larsen, AK; Marcus, MM; Pouzet, B; Ramirez, T; Svensson, TH; Søby, KK	1
Härkänen, T; Haukka, J; Lönnqvist, J; Tiihonen, J	1
Preuss, UW; Wustmann, T	1
Graudins, A; Green, D; Morris, E	1
Bodmer, M; Bruggisser, M; Rätz Bravo, A	1
Fisar, Z; Hroudová, J; Raboch, J	1
Li, M; Sparkman, NL	1
Gerona, RR; Lung, DD; Wu, AH	1
Carlo, S; Castaing-Lespier, PA; Sabaté, N; Santos-Cubiñá, J; Torres-Martin, A; Torres-Rodríguez, A	1
Bernardo, M; Caballero, M; Corripio, I; Felipe, AE; Fernandez de Corres, B; González Piqueras, JC; Huerta, R; Ibáñez, A; Iniesta, R; López-Carrilero, R; Oliveira, C; Roca, M; Rodriguez-Jimenez, R; Sindreu, SD; Usall, J	1
Asaoka, N; Kaneko, S; Nagayasu, K; Nakagawa, T; Nishitani, N; Shirakawa, H; Yamashiro, M	1
Amerio, A; Ghaemi, SN; Odone, A; Stubbs, B; Tonna, M	1
Andersen, L; Gih, DE; LaRosa, C	1
Kanwar, P; Kumar, R; Sharma, RC	1
Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN	1
Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S	1
Bakırdere, S; Chormey, DS; Dalgıç Bozyiğit, G; Fırat Ayyıldız, M; Onkal Engin, G	1
Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH	1

Reviews

4 review(s) available for citalopram and olanzapine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Turner-syndrome and psychosis: a case report and brief review of the literature]. Psychiatrische Praxis, 2009, Volume: 36, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Chromosome Aberrations; Citalopram; Combined Modality Therapy; Drug Therapy, Combination; Female; Hallucinations; Humans; Middle Aged; Olanzapine; Patient Education as Topic; Psychotherapy; Psychotic Disorders; Risperidone; Turner Syndrome	2009
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. Psychiatry research, 2021, Volume: 295 Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Citalopram; Dementia; Electroconvulsive Therapy; Haloperidol; Humans; Olanzapine; Psychopharmacology; Risperidone	2021
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder. Acta psychiatrica Scandinavica, 2022, Volume: 146, Issue:4 Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride	2022

Trials

5 trial(s) available for citalopram and olanzapine

Article	Year
First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression. Neuropsychobiology, 2001, Volume: 43, Issue:3 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Inpatients; Male; Middle Aged; Olanzapine; Paroxetine; Patient Discharge; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2001
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2001, Volume: 5 Suppl A Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Dibenzothiazepines; Female; Humans; Male; Neuronal Ceroid-Lipofuscinoses; Olanzapine; Pilot Projects; Pirenzepine; Quetiapine Fumarate; Risperidone	2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2001,Fall, Volume: 9, Issue:4 Topics: Aged; Algorithms; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Citalopram; Cost-Benefit Analysis; Humans; Olanzapine; Patient Compliance; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome	2001
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Olanzapine; Psychiatric Status Rating Scales; Reboxetine; Risperidone; Schizophrenia; Schizophrenic Psychology	2014

Other Studies

36 other study(ies) available for citalopram and olanzapine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
[Olanzapine in the treatment of depressive disorders with psychotic symptoms]. Der Nervenarzt, 1999, Volume: 70, Issue:1 Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Female; Humans; Middle Aged; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors	1999
Summary from the 153rd meeting of the American Psychiatric Association. 13-18 May 2000, Chicago, Illinois, USA. Expert opinion on pharmacotherapy, 2000, Volume: 1, Issue:5 Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Depressive Disorder; Humans; Hypericum; Olanzapine; Phytotherapy; Pirenzepine; Plants, Medicinal; Psychiatry; Psychotropic Drugs; Societies, Scientific; Testosterone; United States	2000
Can olanzapine be implicated in causing serotonin syndrome? Psychiatry and clinical neurosciences, 2002, Volume: 56, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Female; Humans; Lithium Chloride; Middle Aged; Olanzapine; Pirenzepine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2002
Olanzapine and serotonin toxicity. Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Citalopram; Drug Therapy, Combination; Humans; Olanzapine; Paroxetine; Pirenzepine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2003
Olanzapine-induced neutropenia: mechanism and treatment. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:2 Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Cell Count; Citalopram; Dose-Response Relationship, Drug; Female; Humans; Neutropenia; Olanzapine	2004
Cotard's syndrome and electroconvulsive therapy. Psychiatric services (Washington, D.C.), 2004, Volume: 55, Issue:11 Topics: Benzodiazepines; Citalopram; Combined Modality Therapy; Delusions; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Middle Aged; Olanzapine; Syndrome	2004
Delusional wife: a case of diagnostic ambiguity and treatment challenge. Journal of psychiatric practice, 2005, Volume: 11, Issue:3 Topics: Adult; Alcoholism; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Hospitalization; Humans; Male; Marijuana Abuse; Olanzapine; Patient Readmission; Psychotic Disorders; Spouses	2005
Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. Journal of forensic sciences, 2005, Volume: 50, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Autopsy; Benzodiazepines; Citalopram; Drug Overdose; Humans; Male; Olanzapine; Postmortem Changes; Schizophrenia, Paranoid; Tissue Distribution	2005
[Brief case report. Duloxetine in Cotard syndrome]. Psychiatrische Praxis, 2005, Volume: 32, Issue:8 Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depersonalization; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Olanzapine; Risperidone; Syndrome; Thiophenes	2005
[A 74-year-old unconscious woman with myoclonia and seizures]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Sep-07, Volume: 126, Issue:17 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Female; Fluoxetine; Humans; Mianserin; Myoclonus; Olanzapine; Poisoning; Seizures; Selective Serotonin Reuptake Inhibitors; Unconsciousness	2006
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome	2008
Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsych European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Animals, Outbred Strains; Benzodiazepines; Cebus; Citalopram; Clozapine; Cognition; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Haloperidol; Haplorhini; Humans; Indoles; Male; Mice; Molecular Structure; Motor Activity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D4; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulfonamides	2007
Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:7 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Citalopram; Cohort Studies; Drug Therapy, Combination; Female; Finland; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Risk Factors; Schizophrenia; Suicide; Suicide Prevention; Suicide, Attempted	2008
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009, Volume: 5, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Chlorpromazine; Citalopram; Combined Modality Therapy; Dopamine Agonists; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Hypothermia, Induced; Infusions, Intravenous; Midazolam; Neuroleptic Malignant Syndrome; Olanzapine; Respiration, Artificial; Treatment Outcome	2009
[Medication associated long QT syndrome]. Praxis, 2009, Dec-02, Volume: 98, Issue:24 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Humans; Long QT Syndrome; Olanzapine; Schizophrenia, Paranoid; Syncope, Vasovagal	2009
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro endocrinology letters, 2010, Volume: 31, Issue:5 Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride	2010
Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia. Behavioural pharmacology, 2012, Volume: 23, Issue:7 Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Citalopram; Conditioning, Psychological; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Haloperidol; Male; Olanzapine; Polypharmacy; Random Allocation; Rats; Rats, Sprague-Dawley; Schizophrenia	2012
Cardiotoxicity in a citalopram and olanzapine overdose. The Journal of emergency medicine, 2013, Volume: 45, Issue:4 Topics: Adult; Benzodiazepines; Bradycardia; Citalopram; Drug Overdose; Electrocardiography; Humans; Hypotension; Male; Olanzapine; Seizures; Selective Serotonin Reuptake Inhibitors; Young Adult	2013
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report. Boletin de la Asociacion Medica de Puerto Rico, 2013, Volume: 105, Issue:3 Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Carnitine; Citalopram; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Substitution; Drug Therapy, Combination; Humans; Hyperammonemia; Ketoglutarate Dehydrogenase Complex; Lorazepam; Male; Mood Disorders; Olanzapine; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Valproic Acid	2013
Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus. Neuropharmacology, 2015, Volume: 95 Topics: Animals; Antidepressive Agents; Benzodiazepines; Bicuculline; Citalopram; Depressive Disorder; Disease Models, Animal; Dorsal Raphe Nucleus; Female; Fluoxetine; GABA-A Receptor Antagonists; GABAergic Neurons; Male; Mice, Inbred C57BL; Neural Inhibition; Olanzapine; Piperazines; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin Antagonists; Sulfonamides; Tissue Culture Techniques	2015
Treatment of comorbid bipolar disorder and anxiety disorders: A great challenge to modern psychiatry. The Australian and New Zealand journal of psychiatry, 2016, Volume: 50, Issue:7 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Comorbidity; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Valproic Acid	2016
Reexamining the Role of Electroconvulsive Therapy in Anorexia Nervosa in Adolescents. The journal of ECT, 2017, Volume: 33, Issue:4 Topics: Adolescent; Anorexia Nervosa; Benzodiazepines; Citalopram; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Olanzapine; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome	2017
Cannabis induced koro in a Nepali migrant. Asian journal of psychiatry, 2018, Volume: 31 Topics: Adult; Cannabis; Citalopram; Clonazepam; GABA Modulators; Humans; Koro; Male; Nepal; Olanzapine; Selective Serotonin Reuptake Inhibitors; Transients and Migrants	2018
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. Pharmacopsychiatry, 2021, Volume: 54, Issue:3 Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Valproic Acid; Venlafaxine Hydrochloride	2021
Dispersive Liquid-Liquid Microextraction Based Preconcentration of Selected Pesticides and Escitalopram Oxalate, Haloperidol, and Olanzapine from Wastewater Samples Prior to Determination by GC-MS. Journal of AOAC International, 2021, Mar-05, Volume: 104, Issue:1 Topics: Citalopram; Gas Chromatography-Mass Spectrometry; Haloperidol; Humans; Limit of Detection; Liquid Phase Microextraction; Olanzapine; Pesticides; Wastewater; Water Pollutants, Chemical	2021